医学部 乳腺外科

松原 礼明

Matsubara Hiroaki

基本情報

所属
藤田医科大学 医療科学部 准教授
学位
博士(理学)(2010年9月 大阪大学)

研究者番号
10598288
ORCID ID
 https://orcid.org/0000-0002-8408-4234
J-GLOBAL ID
201801001742706421
researchmap会員ID
B000315989

2010年、大阪大学にて博士(理学)取得。博士論文は原子核物理(実験)に関するテーマ。2013年より医学物理分野に転向。2016年、医学物理士に認定。

主要な学歴

 2

主要な論文

 144
  • Hiroaki Matsubara, Kanna Sagara, Shuhei Shimotake
    Radiation Physics and Chemistry 2026年2月  査読有り筆頭著者責任著者
  • Hiroaki Matsubara
    Radiological Physics and Technology 2023年2月13日  査読有り筆頭著者責任著者
  • Hiroaki Matsubara, Takatomo Ezura, Yaichiro Hashimoto, Kumiko Karasawa, Teiji Nishio, Masato Tsuneda
    Journal of Radiation Research 2021年9月20日  査読有り筆頭著者責任著者
    <title>Abstract</title> Cardiac implantable electronic devices (CIEDs) were believed to have a tolerance dose and that direct irradiation has to be avoided. Thus, no clinical guidelines have mentioned the feasibility of total body irradiation (TBI) with a CIED directly. The purpose of this work was to study a feasible and safe condition for TBI using a CIED. Eighteen CIEDs were directly irradiated by a 6-MV X-ray beam, where a non-neutron producible beam was employed for the removal of any neutron contribution to CIED malfunction. Irradiation up to 10 Gy in accumulated dose was conducted with a 100-cGy/min dose rate, followed by up to 20 Gy at 200 cGy/min. An irradiation test of whether inappropriate ventricular shock therapy was triggered or not was also performed by using a 6-MV beam of 5, 10, 20 and 40 cGy/min to two CIEDs. No malfunction was observed during irradiation up to 20 Gy at 100 and 200 cGy/min without activation of shock therapy. These results were compared with typical TBI, suggesting that a CIED in TBI will not encounter malfunction because the prescribed dose and the dose rate required for TBI are much safer than those used in this experiment. Several inappropriate shock therapies were, however, observed even at 10 cGy/min if activated. The present result suggested that TBI was feasible and safe if a non-neutron producible beam was employed at low dose-rate without activation of shock therapy, where it was not inconsistent with clinical and non-clinical data in the literature. The feasibility of TBI while using a CIED was discussed for the first time.
  • Hiroaki Matsubara, Atsushi Tamii
    Frontiers in Astronomy and Space Sciences 8 2021年7月14日  査読有り筆頭著者責任著者
  • Hiroaki Matsubara, Takatomo Ezura, Yaichiro Hashimoto, Kumiko Karasawa, Teiji Nishio, Masato Tsuneda
    Medical physics 2020年1月31日  査読有り筆頭著者責任著者
    PURPOSE: Cardiac implantable electronic devices (CIEDs) were believed to possess a tolerance dose to malfunction during radiotherapy. Although recent studies have qualitatively suggested neutrons as a cause of malfunction, numerical understanding has not been reached. The purpose of this work is to quantitatively clarify the contribution of secondary neutrons from out-of-field irradiation to the malfunction of CIEDs as well as to deduce the frequency of malfunctions until completion of prostate cancer treatment as a typical case. MATERIALS AND METHODS: Measured data were gathered from the literature and were re-analyzed. Firstly, linear relationship for a number of malfunctions to the neutron dose was suggested by theoretical consideration. Secondly, the accumulated number of malfunctions of CIEDs gathered from the literature was compared with the prescribed dose, scattered photon dose, and secondary neutron dose for analysis of their correlation. Thirdly, the number of malfunctions during a course of prostate treatment with high-energy X-ray, passive proton and passive carbon-ion beams was calculated while assuming the same response to malfunctions, where X-rays consisted of 6-MV, 10-MV, 15-MV, and 18-MV beams. Monte Carlo simulation assuming simple geometry was performed for the distribution of neutron dose from X-ray beams, where normalization factors were applied to the distribution so as to reproduce the empirical values. RESULTS: Linearity between risk and neutron dose was clearly found from the measured data, as suggested by theoretical consideration. The predicted number of malfunctions until treatment completion was 0, 0.02±0.01, 0.30±0.08, 0.65±0.17, 0.88±0.50, and 0.14±0.04 when 6-MV, 10-MV, 15-MV, 18-MV, passive proton, and passive carbon-ion beams, respectively, were employed, where the single model response to a malfunction of 8.6±2.1 Sv-1 was applied. CONCLUSIONS: Numerical understanding of the malfunction of CIEDs has been attained for the first time. It has been clarified that neutron dose is a good scale for the risk of CIEDs in radiotherapy. Prediction of the frequency of malfunction as well as discussion of the risk to CIEDs in radiotherapy among the multiple modalities have become possible. Because the present study quantitatively clarifies the neutron contribution to malfunction, revision of clinical guidelines is suggested.
  • Matsubara H, Karasawa K, Furuichi W, Wakaisami M, Shiba S, Wakatsuki M, Omatsu T, Inaniwa T, Fukuda S, Kamada T
    Journal of radiation research 59(5) 625-631 2018年9月  査読有り筆頭著者責任著者
  • Hiroaki Matsubara, Kumiko Karasawa, Naruhiro Matsufuji, Hiroshi Tsuji, Naoyoshi Yamamoto, Mio Nakajima, Masataka Karube, Wataru Takahashi
    MEDICAL PHYSICS 43(5) 2689 2016年5月  査読有り筆頭著者責任著者
  • H. Matsubara, A. Tamii, H. Nakada, T. Adachi, J. Carter, M. Dozono, H. Fujita, K. Fujita, Y. Fujita, K. Hatanaka, W. Horiuchi, M. Itoh, T. Kawabata, S. Kuroita, Y. Maeda, P. Navratil, P. von Neumann-Cosel, R. Neveling, H. Okamura, L. Popescu, I. Poltoratska, A. Richter, B. Rubio, H. Sakaguchi, S. Sakaguchi, Y. Sakemi, Y. Sasamoto, Y. Shimbara, Y. Shimizu, F. D. Smit, K. Suda, Y. Tameshige, H. Tokieda, Y. Yamada, M. Yosoi, J. Zenihiro
    PHYSICAL REVIEW LETTERS 115(10) 2015年9月  査読有り筆頭著者責任著者
  • H. Matsubara, N. Matsufuji, H. Tsuji, N. Yamamoto, K. Karasawa, M. Nakajima, W. Takahashi, M. Karube
    MEDICAL PHYSICS 42(9) 5568-5577 2015年9月  査読有り筆頭著者責任著者
  • H. Matsubara, M. Takaki, T. Uesaka, S. Shimoura, N. Aoi, M. Dozono, T. Fujii, K. Hatanaka, T. Hashimoto, T. Kawabata, S. Kawase, K. Kisamori, Y. Kikuch, Y. Kubota, C. S. Lee, H. C. Lee, Y. Maeda, S. Michimasa, K. Miki, H. Miya, S. Noji, S. Ota, S. Sakaguchi, Y. Sasamoto, T. Suzuki, L. T. Tang, K. Takahisa, H. Tokieda, A. Tamii, K. Yako, Y. Yasuda, N. Yokota, R. Yokoyama, J. Zenihiro
    Few-Body Systems 54(7-10) 1433-1436 2013年8月  査読有り筆頭著者責任著者
  • H. Matsubara, A. Tamii, Y. Shimizu, K. Suda, Y. Tameshige, J. Zenihiro
    NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT 678 122-129 2012年6月  査読有り筆頭著者責任著者
  • H. Matsubara, H. Sakaguchi, T. Kishi, A. Tamii
    Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions with Materials and Atoms 267(23-24) 3682-3687 2009年12月  査読有り筆頭著者責任著者

主要なMISC

 65
  • Hiroaki Matsubara, Hiroaki Matsubara
    Impact 2021(5) 31-33 2021年6月7日  筆頭著者
    Interdisciplinary collaboration is necessary for the advancement of medicine. A lack of collaboration can lead to misconceptions and a lack of theoretical understanding, which can affect the care afforded to patients. With the right collaborations between scientists in fields outside of medicine, misconceptions can be corrected and understanding improved. Assistant Professor Hiroaki Matsubara, Tokyo Women's Medical University, Japan, is a nuclear physicist who is applying his skills and expertise to advance the field of medicine. Nuclear physics is used in several key techniques and tools in medicine such as X-rays and radiotherapy. Matsubara is interested in the issues that can arise in patients with implanted cardiac devices that require radiotherapy. The radiation from radiotherapy can affect the proper functioning of cardiac implantable electronic devices (CIEDs), leading to dangerous malfunctions, even when the tumour being targeted is far from the heart. From gathering data from clinical settings and running tests in non-clinical environments Matsubara found that there was no correlation between photon exposure levels and device malfunction, which suggested another source of malfunction arising after radiotherapy. Using his nuclear expertise, he was able to uncover the source of CIED malfunction following radiotherapy.
  • 松原 礼明
    臨床放射線 62(5) 743-747 2017年5月  

共同研究・競争的資金等の研究課題

 5